Historically, the Food and Drug Administration (FDA) has been defined by a cautious, evidence-first approach to approving new drugs and ingredients
Understanding likely future developments helps inform long-term decisions about peptide use
HUBERMAN: Are the effects of certain peptides on metabolism and growth
Emerg Med J 25:3337 Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, Duplancic B, Uzun S, Zivanovic-Posilovic G, Kolenc D, Drmic D (2016) BPC 157: the counteraction of succinylcholine, hyperkalemia, and arrhythmias
Live & Well Videos Explore the FDA status of popular peptides like BPC-157, GLP-1s, Tesamorelin, and PT-141, while learning why unmonitored online ordering poses serious safety risks